Evogene (EVGN)
(Real Time Quote from BATS)
$2.07 USD
-0.17 (-7.59%)
Updated Nov 4, 2024 02:50 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EVGN 2.07 -0.17(-7.59%)
Will EVGN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for EVGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EVGN
Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
EVGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy
Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?
Other News for EVGN
Lake Street Sticks to Their Buy Rating for Evogene (EVGN)
Evogene announces collaboration with Google Cloud
Evogene announces collaboration with Google Cloud
RBC Capital Sticks to Their Hold Rating for EverGen Infrastructure Corp. (EVGN)
EverGen Switches Auditors, Ensures Smooth Transition